Discovering new relationships is how Life Science orientates itself. At Tech ICS our technologies work no differently, we’re believers in new bioscience. We build innovative platforms to field better research tools, process fundamental data for the next generation of solutions. 

Phil Thomson, President, Global Affairs, at GSK said:

“The UK is a powerhouse for life sciences and GSK welcomes the vision set out today by Sir John Bell for the sector’s future. At the core of this new industrial strategy is a stronger and deeper level of collaboration between industry, government, the NHS, academia and funders. Working together, we can make the UK internationally competitive in life sciences for the long-term, capitalising on the country’s world-class science base and realising innovation to drive economic growth and improve patient care. As the UK’s largest life sciences company and one of its biggest investors in research, we look forward to contributing to this effort.”

At Tech ICS we second exactly how Phil Thomson addresses a new field of research, and our technology revolutions work parallel. We work to innovate and live to disrupt. Speak to us and find out how we can make a difference to your business.